Iwijn de Vlaminck, PhD

Meinig School of Biomedical Engineering – Cornell University

Disclosure(s): GenDX: Advisor/Consultant, Board Member; Kanvas Biosciences: Board Member, Ownership Interest; Karius Inc.: Board Member, Ownership Interest; Viracor Eurofins: Advisor/Consultant

Poster(s):

• 494 - Enteric bacteria are immune-reactive in patients with Crohn's disease with extraintestinal manifestations
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET